These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 10422989)

  • 1. Managed care market share, fee-for-service Medicare, and information theory.
    Blanco C; Olfson M; Blanco-Jerez C
    JAMA; 1999 Jul; 282(3):235-6. PubMed ID: 10422989
    [No Abstract]   [Full Text] [Related]  

  • 2. Association of managed care market share and health expenditures for fee-for-service Medicare patients.
    Baker LC
    JAMA; 1999 Feb; 281(5):432-7. PubMed ID: 9952203
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of HMOs on fee-for-service health care expenditures: evidence from Medicare.
    Baker LC
    J Health Econ; 1997 Aug; 16(4):453-81. PubMed ID: 10169101
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of HMOs on fee-for-service health care expenditures: evidence from Medicare revisited.
    Batata A
    J Health Econ; 2004 Sep; 23(5):951-63. PubMed ID: 15353188
    [TBL] [Abstract][Full Text] [Related]  

  • 5. How Medicare HMOs manipulate the market.
    Hosp Health Netw; 1995 Nov; 69(21):12. PubMed ID: 7581602
    [No Abstract]   [Full Text] [Related]  

  • 6. Do increases in the market share of managed care influence quality of cancer care in the fee-for-service sector?
    Keating NL; Landrum MB; Meara E; Ganz PA; Guadagnoli E
    J Natl Cancer Inst; 2005 Feb; 97(4):257-64. PubMed ID: 15713960
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disenrollment from Medicare HMOs.
    Call KT; Dowd BE; Feldman R; Lurie N; McBean MA; Maciejewski M
    Am J Manag Care; 2001 Jan; 7(1):37-51. PubMed ID: 11209449
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Health care use and expenditures of Medicare HMO disenrollees.
    Parente ST; Evans WN; Schoenman JA; Finch MD
    Health Care Financ Rev; 2005; 26(3):31-43. PubMed ID: 17290626
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biased selection and Medicare HMOs: analysis of the 1989-1994 experience.
    Cox DF; Hogan C
    Med Care Res Rev; 1997 Sep; 54(3):259-74; discussion 275-85. PubMed ID: 9437168
    [No Abstract]   [Full Text] [Related]  

  • 10. Increased Medicare expenditures for physicians' services: what are the causes?
    Buntin MJ; Escarcé JJ; Goldman D; Kan H; Laugesen MJ; Shekelle P
    Inquiry; 2004; 41(1):83-94. PubMed ID: 15224962
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stats & facts. Medicare and pharmaceutical coverage.
    Manag Care Interface; 1999 Apr; 12(4):68-9. PubMed ID: 10387395
    [No Abstract]   [Full Text] [Related]  

  • 12. The impact of payor/provider type on health care use and expenditures among the frail elderly.
    Experton B; Li Z; Branch LG; Ozminkowski RJ; Mellon-Lacey DM
    Am J Public Health; 1997 Feb; 87(2):210-6. PubMed ID: 9103099
    [TBL] [Abstract][Full Text] [Related]  

  • 13. What can be learned about the ethical soundness of Medicare HMOs from studies comparing them to fee-for-service Medicare?
    Wicclair MR
    J Ethics Law Aging; 1999; 5(1):29-49. PubMed ID: 11657821
    [No Abstract]   [Full Text] [Related]  

  • 14. Use of ineffective or unsafe medications among members of a Medicare HMO compared to individuals in a Medicare fee-for-service program.
    Futterman R; Fillit H; Roglieri JL
    Am J Manag Care; 1997 Apr; 3(4):569-75. PubMed ID: 10169525
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of Medicare health care systems on women with breast and cervical cancer.
    Kirsner RS; Ma F; Fleming L; Trapido E; Duncan R; Federman DG; Wilkinson JD
    Obstet Gynecol; 2005 Jun; 105(6):1381-8. PubMed ID: 15932833
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mortality, Hospitalizations, and Expenditures for the Medicare Population Aged 65 Years or Older, 1999-2013.
    Krumholz HM; Nuti SV; Downing NS; Normand SL; Wang Y
    JAMA; 2015 Jul; 314(4):355-65. PubMed ID: 26219053
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Medicare Advantage and the impact of Medicare HMOs on inpatient utilization.
    Minott J
    Find Brief; 2007 Oct; 10(9):1-3. PubMed ID: 18019951
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Medicare-HMO revolving door--the healthy go in and the sick go out.
    Morgan RO; Virnig BA; DeVito CA; Persily NA
    N Engl J Med; 1997 Jul; 337(3):169-75. PubMed ID: 9219704
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HMO penetration, competition, and risk-adjusted hospital mortality.
    Mukamel DB; Zwanziger J; Tomaszewski KJ
    Health Serv Res; 2001 Dec; 36(6 Pt 1):1019-35. PubMed ID: 11775665
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of insurance type on prescription drug use and expenditures among elderly Medicare beneficiaries.
    Saleh SS; Weller W; Hannan E
    J Health Hum Serv Adm; 2007; 30(1):50-74. PubMed ID: 17557696
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.